These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34662566)

  • 1. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
    Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
    Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
    Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
    Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    J Ocul Pharmacol Ther; 2021 Sep; 37(7):412-420. PubMed ID: 34252290
    [No Abstract]   [Full Text] [Related]  

  • 7. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
    Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
    Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.
    Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A
    Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
    Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
    Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
    Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.
    Chen B; Cao S; Zhang Y; Wang X; Liu J; Hui X; Wan Y; Du W; Wang L; Wu K; Fan D
    BMC Cell Biol; 2009 Sep; 10():63. PubMed ID: 19740430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pathological retinal neovascularization by semaphorin 3A.
    Yu W; Bai Y; Han N; Wang F; Zhao M; Huang L; Li X
    Mol Vis; 2013; 19():1397-405. PubMed ID: 23825919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
    Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
    Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903.
    Ding J; Li B; Zhang H; Xu Z; Zhang Q; Ye R; Feng S; Jiang Q; Zhu W; Yan B
    Transl Vis Sci Technol; 2022 Dec; 11(12):8. PubMed ID: 36484641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.